Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal
- PMID: 22788235
- DOI: 10.1007/BF03261962
Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal
Abstract
Background: Spontaneous reporting of adverse drug reactions (ADRs) is the method most widely used by pharmacovigilance systems, with the principal limitation being the physician's underreporting.
Objective: This study sought to evaluate the results of workshop and telephone-interview interventions designed to improve the quantity and relevance of ADR reporting by physicians.
Methods: A cluster-randomized controlled trial was conducted on 6579 physicians in northern Portugal in 2008. Following randomization, we allocated 1034 physicians to a telephone-interview intervention, 438 to a workshop intervention and the remaining 5107 to the control group. At the workshop, a real clinical case was presented and participants were then asked to report on it by completing the relevant form. In the telephone intervention, participants were asked (i) whether they had ever had any suspicion of ADRs; (ii) whether they had experienced any difficulties in reporting; (iii) whether they remembered the different methods that could be used for reporting purposes; and (iv) whether they attached importance to the individual physician's role in reporting. We followed up physicians to assess ADR reporting rates to the Northern Pharmacovigilance Centre. In terms of relevance, adverse reactions were classified as serious or unexpected. Statistical analysis was performed on an intention-to-treat basis, and generalized linear mixed models were applied using the penalized quasi-likelihood method. The physicians studied were followed up over a period of 20 months.
Results: Two hundred physicians underwent the educational intervention. Comparison with the control group showed that the workshop intervention increased the spontaneous ADR reporting rate by an average of 4-fold (relative risk [RR] 3.97; 95% CI 3.86, 4.08; p < 0.001) across the 20 months post-intervention. Telephone interviews, in contrast, proved less efficient since they led to no significant difference (p = 0.052) vis-à-vis the control group in ADR reporting (RR 1.02; 95% CI 1.00, 1.04). The effects of the interventions on the reporting rate of serious and high-causality ADRs indicated that the RRs associated with workshops were 6.84 (95% CI 6.69, 6.98; p < 0.001) for serious ADRs and 3.58 (95% CI 3.51, 3.66; p < 0.001) for high-causality ADRs.
Conclusions: Whereas telephone interventions only increased spontaneous reporting in the first 4 months of follow-up, workshops significantly increased both the quantity and relevance of spontaneous ADR reporting for more than 1 year.
Similar articles
-
An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.JAMA. 2006 Sep 6;296(9):1086-93. doi: 10.1001/jama.296.9.1086. JAMA. 2006. PMID: 16954488 Clinical Trial.
-
Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal.Drug Saf. 2008;31(4):335-44. doi: 10.2165/00002018-200831040-00007. Drug Saf. 2008. PMID: 18366244 Clinical Trial.
-
Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal.Drug Saf. 2012 May 1;35(5):387-94. doi: 10.2165/11597190-000000000-00000. Drug Saf. 2012. PMID: 22468615
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
-
Systematic review and meta-analysis on effectiveness of strategies for enhancing adverse drug reaction reporting.J Am Pharm Assoc (2003). 2025 Jan-Feb;65(1):102293. doi: 10.1016/j.japh.2024.102293. Epub 2024 Nov 9. J Am Pharm Assoc (2003). 2025. PMID: 39522823
Cited by
-
Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.Eur J Clin Pharmacol. 2015 Jul;71(7):883-90. doi: 10.1007/s00228-015-1867-2. Epub 2015 May 26. Eur J Clin Pharmacol. 2015. PMID: 26004569
-
Workshop on Adverse Drug Reaction Reporting, Pharmacovigilance and Its Implementation in Cancer Hospital in Nepal: An Event Report.Adv Med Educ Pract. 2020 Jan 8;11:9-14. doi: 10.2147/AMEP.S225208. eCollection 2020. Adv Med Educ Pract. 2020. PMID: 32021537 Free PMC article.
-
Evolution of adverse drug reactions reporting systems: paper based to software based.Eur J Clin Pharmacol. 2022 Sep;78(9):1385-1390. doi: 10.1007/s00228-022-03358-3. Epub 2022 Jul 5. Eur J Clin Pharmacol. 2022. PMID: 35788724
-
Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature.Eur J Clin Pharmacol. 2018 Oct;74(10):1235-1248. doi: 10.1007/s00228-018-2500-y. Epub 2018 Jun 20. Eur J Clin Pharmacol. 2018. PMID: 29926135 Free PMC article. Review.
-
Increasing adverse drug reaction reporting-How can we do better?PLoS One. 2020 Aug 13;15(8):e0235591. doi: 10.1371/journal.pone.0235591. eCollection 2020. PLoS One. 2020. PMID: 32790671 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials